SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novavax NVAX
NVAX 8.400-0.4%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: recycled_electron7/12/2022 4:40:34 PM
  Read Replies (1) of 166
 
Possible FDA approval (for primary vaccination series in the US) tomorrow (July 13). Next stop: CDC approval. Also, NVAX announced an agreement for the USG to procure 3.2m doses.
politico.com
ir.novavax.com

While the long awaited approval for primary series will be very welcome, it is time for the Omicron one to be available as an approved booster:
ir.novavax.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext